Trial Profile
Effect of antidiabetic drug on endothelial function
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms EFFORT
- 18 Mar 2018 Status changed from active, no longer recruiting to completed.
- 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Sep 2017 New trial record